RT @InfinixBio: This #research, co-athored by Rich Brody and Sonnet BioTherapeutics, addresses the challenges in solid tumor #immunotherapy…
12,151 followers
174 followers
This #research, co-athored by Rich Brody and Sonnet BioTherapeutics, addresses the challenges in solid tumor #immunotherapy, aiming to enhance cytokine half-life, target tumors, and amplify #therapeutic efficacy. https://t.co/6yRgmfOV9K
31 followers
RT @FrontImmunol: New Research: SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumo…
40 followers
RT @FrontImmunol: New Research: SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumo…